Leveraging a solid foundation in technology and healthcare, the fund manager has executed over 35 investments across North America and Europe. With a strong operator-first approach, the manager has successfully navigated various growth stages, facilitating notable exits in the biotech sector. Their strategic style emphasizes data-driven decision-making, allowing them to identify and capitalize on emerging trends effectively. This experience underscores a commitment to fostering innovation and delivering substantial returns for investors.